GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently gaining a major focus in therapeutic investigation, largely due to its impressive impact on managing diseases such as adult-onset diabetes and obesity. Recent studies have shown that more than glucose control, GLP-1 agonists offer promise for circulatory function and even c… Read More